1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with hirudin in 18 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (hirudin) | Trials (hirudin) | Recent Studies (post-2010) (hirudin) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 3,658 | 378 | 995 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (44.44) | 18.7374 |
| 1990's | 7 (38.89) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akkerman, JW; van Willigen, G | 1 |
| Butler, KD; Crook, P; May, GR; Page, CP; Paul, W | 1 |
| Eldor, A; Hy-Am, E; Matzner, Y; Orevi, M; Rigbi, M | 1 |
| Bellinger, OK; Breddin, HK; Kirchmaier, CM; Schulz, B | 1 |
| Glusa, E | 1 |
| Maraganore, JM; McIntyre, TM; Prescott, SM; Seeger, AR; Zimmerman, GA | 1 |
| Petty, AC; Scrutton, MC | 1 |
| Aglietta, M; Breviario, F; Bussolino, F; Dejana, E; Mantovani, A; Tetta, C | 1 |
| Dejana, E; Prosdocimi, M; Zanetti, A; Zatta, A | 1 |
| Grignani, G; Jamieson, GA | 1 |
| Ma, YH; Ouyang, CH; Teng, CM | 1 |
| Korth, R; Mangold, HK; Muramatsu, T; Zöllner, N | 1 |
| Hillmar, I; Korth, R; Muramatsu, T; Zöllner, N | 1 |
| Cox, CP; Farr, RS; Jorgensen, R; Wardlow, ML | 1 |
| Bretschneider, E; Glusa, E; Schrör, K | 1 |
| Fox, SC; Heptinstall, S; White, AE; Wilcox, RG; Xavier, RG | 1 |
| Schneider, DJ; Sobel, BE | 1 |
| Ivashin, DS; Olkhovsky, IA; Stolyar, MA | 1 |
18 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and hirudin
| Article | Year |
|---|---|
Regulation of glycoprotein IIB/IIIA exposure on platelets stimulated with alpha-thrombin.
Topics: Alkaloids; Binding Sites; Blood Platelets; Bucladesine; Epoprostenol; Fibrinogen; Fibronectins; Hirudins; Humans; Platelet Activating Factor; Platelet Membrane Glycoproteins; Protein Kinase C; Staurosporine; Thrombin | 1992 |
The pharmacological modulation of thrombin-induced cerebral thromboembolism in the rabbit.
Topics: Animals; Anistreplase; Arginine; Blood Platelets; Diterpenes; Female; Fibrinogen; Fibrinolytic Agents; Ginkgolides; Hirudins; Injections, Intra-Arterial; Injections, Intravenous; Intracranial Embolism and Thrombosis; Lactones; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Polydeoxyribonucleotides; Rabbits; Recombinant Proteins; Thrombin | 1992 |
A potent inhibitor of platelet activating factor from the saliva of the leech Hirudo medicinalis.
Topics: Animals; Blood Platelets; Chemical Fractionation; Free Radicals; Hirudins; Humans; In Vitro Techniques; Leeches; Molecular Weight; Neutrophils; Platelet Activating Factor; Platelet Aggregation Inhibitors; Saliva; Thromboxane A2 | 1992 |
Effect of recombinant hirudin on cytosolic Ca2+ concentrations using different platelet stimulators.
Topics: Adenosine Diphosphate; Blood Platelets; Calcium; Chromatography, Gel; Collagen; Cytosol; Dose-Response Relationship, Drug; Drug Interactions; Hirudins; Humans; Ionomycin; Platelet Activating Factor; Platelet Aggregation; Recombinant Proteins; Second Messenger Systems; Thrombin | 1991 |
Platelet aggregation in recombinant-hirudin-anticoagulated blood.
Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Citrates; Citric Acid; Collagen; Drug Synergism; Epinephrine; Hirudins; Humans; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Recombinant Proteins; Serotonin | 1991 |
Hirudin-based peptides block the inflammatory effects of thrombin on endothelial cells.
Topics: Calcimycin; Cells, Cultured; Endothelium, Vascular; Epoprostenol; Hirudins; Humans; Inflammation; Kinetics; Peptide Fragments; Platelet Activating Factor; Thrombin | 1990 |
Platelet aggregation in whole blood: is the response to adrenaline, 5-hydroxytryptamine and PAF a direct consequence of stimulation by these agonists?
Topics: Apyrase; Azepines; Cell Count; Dioxanes; Dose-Response Relationship, Drug; Epinephrine; Hirudins; Humans; Idazoxan; Indomethacin; Ketanserin; Platelet Activating Factor; Platelet Aggregation; Serotonin; Triazines; Triazoles | 1989 |
Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells.
Topics: Acetyl Coenzyme A; Acetyl-CoA C-Acetyltransferase; Aspirin; Cells, Cultured; Chromatography, High Pressure Liquid; Cycloheximide; Dose-Response Relationship, Drug; Endothelium; Hirudins; Humans; Interleukin-1; Lipopolysaccharides; Platelet Activating Factor | 1986 |
At low extracellular calcium concentration platelet activating factor induces beta-thromboglobulin release from human platelets through thromboxane-endoperoxides formation.
Topics: beta-Thromboglobulin; Blood Platelets; Calcium; Female; Heparin; Hirudins; Humans; Male; Platelet Activating Factor; Platelet Aggregation; Thromboxane B2; Thromboxanes | 1987 |
Tissue factor-dependent activation of platelets by cells and microvesicles of SK-OS-10 human osteogenic sarcoma cell line.
Topics: Antibodies; Blood Platelets; Cell Line; Creatine Kinase; Hirudins; Humans; Inclusion Bodies; Lung Neoplasms; Osteosarcoma; Phosphocreatine; Phospholipases; Platelet Activating Factor; Platelet Aggregation; Thromboplastin | 1987 |
Action mechanism of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom.
Topics: Adenosine Diphosphate; Alprostadil; Animals; Arachidonic Acid; Arachidonic Acids; Calcimycin; Chymotrypsin; Collagen; Fibrinogen; Heparin; Hirudins; Platelet Activating Factor; Platelet Aggregation; Prostaglandins E; Rabbits; Thrombin; Viper Venoms | 1985 |
Unsaturated 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholines (unsaturated platelet-activating factor): aggregation of human platelets after incubation with indomethacin, creatinephosphate/creatinephosphokinase, xylocain and hirudine, and serotonin release
Topics: Blood Platelets; Creatine Kinase; Female; Hirudins; Humans; Indomethacin; Lidocaine; Phosphocreatine; Platelet Activating Factor; Platelet Aggregation; Serotonin | 1985 |
1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholines: influence on aggregation and [3H]serotonin release of human thrombocytes.
Topics: Blood Platelets; Hirudins; Humans; Indomethacin; Kinetics; Lidocaine; Phosphocreatine; Platelet Activating Factor; Platelet Aggregation; Serotonin | 1983 |
The presence of platelet-activating factor (PAF) in normal human mixed saliva.
Topics: Adenosine Diphosphate; Adult; Animals; Arachidonic Acids; Creatine Kinase; Dose-Response Relationship, Immunologic; Female; Hirudins; Humans; Indomethacin; Lysophosphatidylcholines; Male; Middle Aged; Platelet Activating Factor; Rabbits; Saliva; Serotonin; Thrombin | 1981 |
ADP-, PAF- and adrenaline-induced platelet aggregation and thromboxane formation are not affected by a thromboxane receptor antagonist at physiological external Ca++ concentrations.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Blood Platelets; Calcium; Citric Acid; Collagen; Epinephrine; Glucose; Hirudins; Humans; Indomethacin; Phenylacetates; Platelet Activating Factor; Platelet Aggregation; Receptors, Thromboxane; Recombinant Proteins; Sulfonamides; Thromboxanes | 1994 |
Enhanced platelet aggregation and activation under conditions of hypothermia.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adenosine Monophosphate; Anticoagulants; Antigens, CD; Aspirin; Blood Platelets; Blood Specimen Collection; Citrates; Cold Temperature; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Hirudins; Humans; Hypothermia, Induced; In Vitro Techniques; P-Selectin; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Platelet Function Tests; Platelet Membrane Glycoproteins; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Receptors, Thrombin; Tetraspanin 30; Time Factors | 2007 |
Streamlining the design of promising clinical trials: in-vitro testing of antithrombotic regimens and multiple agonists of platelet activation.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Animals; Blood Platelets; Clinical Trials as Topic; Coronary Artery Disease; Crotalid Venoms; Drug Evaluation, Preclinical; Drug Therapy, Combination; Eptifibatide; Fibrinolytic Agents; Flow Cytometry; Heparin; Hirudins; Humans; Lectins, C-Type; P-Selectin; Peptide Fragments; Peptides; Pilot Projects; Platelet Activating Factor; Platelet Activation; Platelet Function Tests; Recombinant Proteins; Research Design; Thrombin | 2009 |
[ON THE ISSUE OF SELECTION OF COAGULANTS UNDER ADP-INDUCED IMPEDANCE TEST OF AGGREGATION OF THROMBOCYTES IN PATIENTS WITH CHRONIC MYELO-PROLIFERATIVE TUMORS].
Topics: Adenosine Triphosphate; Adult; Aged; Anticoagulants; Aspirin; Blood Platelets; Citrates; Electric Impedance; Female; Healthy Volunteers; Heparin; Hirudins; Humans; Male; Middle Aged; Myeloproliferative Disorders; Platelet Activating Factor; Platelet Aggregation | 2017 |